Dosik Min

A Colon-Targeted Prodrug, 4-Phenylbutyric Acid-Glutamic Acid Conjugate, Ameliorates 2,4-Dinitrobenzenesulfonic Acid-Induced Colitis in Rats

Seunghyung Lee, Jin-Wook Yoo, Doyoung Kwon, 2020, Pharmaceutics.

Effect of 6,7-dimethoxy-2,2-dimethyl-2H-chromene (agerarin) on the recovery of filaggrin expression through targeting of Janus kinases in the inflammatory skin

Y. Lim, S. Shin, Young Han Lee, 2020, Journal of food and drug analysis.

Inhibition of phospholipase D1 induces immunogenic cell death and potentiates cancer immunotherapy in colorectal cancer

G. Han, Nam-Doo Kim, H. Lee, 2022, Experimental & Molecular Medicine.

Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.

Yunjin Jung, Jeong‐Hyun Yoon, S. Yum, 2012, Molecular pharmaceutics.

Regulation of Epithelial-Mesenchymal Transition of A549 Cells by Prostaglandin D2.

C. Kim, S. Bae, H. Ha, 2022, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology.

Enhanced glutaminolysis drives hypoxia-induced chemoresistance in pancreatic cancer.

H. Lee, T. Ahn, Junjeong Choi, 2023, Cancer research.

Colon-targeted cell-permeable NFκB inhibitory peptide is orally active against experimental colitis.

Yunjin Jung, Jeong‐Hyun Yoon, S. Yum, 2012, Molecular pharmaceutics.